Abstract
Despite the increasing use of implantable devices and ablative procedures, drugs remain the mainstay of therapy for cardiac arrhythmias. The local anesthetic-class drugs are the most widely prescribed antiarrhythmic agents. They exert their antiarrhythmic effect by blockade of the inward sodium current [1]. The adverse impact of drug treatment on survival of patients in Cardiac Arrhythmia Suppression Trial and in patients with atrial fibrillation have forced serious reconsideration of the indications for and selections of drugs [2, 3]. The trial results have also provided a strong impetus for the study of the basic mechanisms of action of these drugs. Such studies may relate basic mechanisms of action to proarrhythmic potential and ultimately lead to safer, more effective treatment. This paper reviews the normal function of the sodium channel, the mechanism(s) of its blockade by drugs and the implication of the blocking mechanisms to the clinical use of these drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Grant AO, Starmer CF, Strauss HC (1984) Antiarrhythmic drug action. Blockade of the inward sodium current. Circ Res 55: 427–439
CAST Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321: 406–412
Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC (1990) Efficacy and safety of quinidine therapy for maintenance of sinus rhythm. Circulation 82: 1106–1116
Reuter H (1974) Exchange of calcium ions in the mammalian myocardium. Circ Res 34: 599–605
Powell T, Twist VW (1976) A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium. Biochem Biophys Res Commun 72: 327–333
Hamill OP, Marty A, Neher E, Sakmann B, Sigworth F (1981) Improved patch-clamp techniques for high-reslution current recording from cell and cell-free membrane patches. Pflugers Arch 391: 85–l00
Miller C (1989) Genetic manipulation of ion channels: a new approach to structure and mechanism. Neuron 2: 1195–1205
Hodgkin AL, Huxley AF (1952) A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol (Lond) 117: 500–544
Armstrong CM (1981) Sodium channels and gating currents. Physiol Rev 61: 644–683
Aldrich RW, Corey DP, Stevens CF (1983) A reinterpretation of mammalian sodium channel gating based on single channel recording. Nature 306: 436–441
Horn R, Vandenberg CA (1984) Statistical properties of single sodium channels. J Gen Physiol 84: 505–534
Vandenberg CA, Horn R (1984) Inactivation viewed through single sodium channels. J Gen Physiol 84: 535–564
Kunze DL, Lacerda AE, Wilson DL, Brown AM (1985) Cardiac Na currents and the inactivating, reopening and waiting properties of single cardiac Na channels. J Gen physiol 86: 697–719
Patlak JB, Ortiz M (1985) Slow currents through single sodium channels of adult rat heart. J Gen Physiol 86: 89–104
Grant AO, Starmer CF (1987) Mechanisms of closure of cardiac sodium channels in rabbit ventricular myocytes: single-channel analysis. Circ Res 60:897–913
Yue DT, Lawrence JH, Marban E (1989) Two molecular transitions influence cardiac sodium channel gating. Science 244: 349–352
Berman MF, Camardo JS, Robinson RB, Siegelbaum SA (1989) Single sodium channels from canine ventricular myocytes: voltage dependence and relative rates of activation and inactivation. J Physiol (Lond) 415: 503–531
Aldrich RW, Stevens CF (1987) Voltage-dependent gating of single sodium channels mammalian neuroblastoma cells. J Neurosci 7: 418–431
Johnson EA, McKinnon MG (1957) The differential effect of quinidine and pyrilamine on the myocardial action potential at various rates of stimulation. J Pharmacol Exp Ther 120: 460–468
Weidmann S(1995) Efects of calcium ions and local anaesthetics on electrical properties of Purkinje fibers. J Physiol (Lond) 129:568–582
Courtney KR (1975) Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA 9681. J Pharmacol Exp Ther 195: 225–236
Courtney KR, Kendig JJ, Cohen EN (1978) The rates of interaction of local anesthetics with sodium channels in nerve. J Pharmacol Exp Ther 207:594–604
Hille B (1977) Local anesthetics: hydrophilic and hydrophobic pathways for the drug, receptor reaction. J Gen Physiol 69: 497–515
Hondeghem LM, Katzung BG (1977) Time-and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 472: 373–398
Khodorov B, Shishkova L, Peganov E, Revenko S (1976) Inhibition of sodium currents in from Ranvier node treated with local anesthetics. Role of slow sodium inactivation. Biochim Biophys Acta 433: 409–435
Courtney KR (1983) Quantifying antiarrhythmic drug blocking during action potentials in guinea-pig papillary muscle. J Mol Cell Cardiol 15: 749–757
Starmer CF, Grant AO, Strauss HC (1984) Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. Biophys J 46: 15–27
Colatsky TJ (1980) Voltage clamp measurements of sodium channel properties in rabbit cardiac Purkinje fibres. J Physiol (Lond) 305: 215–234
Brown AM, Lee KS, Powell T (1981) Sodium current in single rat heart muscle cells. J Physiol (Lond) 318: 479–500
Brown AM, Lee KS, Powell T (1981) Voltage clamp and internal perfusion of single rat heart muscle cells. J Physiol (Lond) 318: 455–477
Moczydlowski E, Uehara A, Hall S (1986) Blocking pharmacology of batrachotoxinactivated sodium channels. In: Miller C (ed) Ion channel reconstitution. Plenum, New York, pp 487–492
Zamponi GW, Doyle DD, French RJ (1993) Fast lidocaine block of cardiac and sheletal muscle sodium channels. One site with two routes of access. Biophys J 65: 80–90
Sheldon RS, Cannon NJ, Duff HJ (1987) A receptor for type 1 antiarrhythmic drugs associated with a rat cardiac sodium channels. Circ Res 61: 492–497
Kodama I, Toyama, J, Yamada K (1987) Block of activated and inactivated sodium channels by class-1 antiarrhythmic drugs studied by using the maximum upstroke velocity (Vmax) of action potential in guinea pig ventricular muscles. J Mol Cell Cardiol 19: 367–377
Gilliam III FR, Starmer CF, Grant AO (1989) Blockade of rabbit atrial sodium channels by lidocaine: characterization of continuous and frequency-dependent blocking. Circ Res 65: 723–739
Sanchez-Chapula J, Tsuda Y, Josephson IR (1983) Voltage-and use-dependent effects of lidocaine on sodium current in rat single ventricular cells. Circ Res 52: 557–565
Clarkson CW, Follmer CH, Ten Eick RE, Hondeghem LM, Yeh JZ (1988) Evidence for two components of sodium channel block by lidocaine in isolated cardiac myocytes. Circ Res 63: 869–878
Benz I, Kohlhardt M (1991) Responsiveness of cardiac Na+ channels to antiarrhythmic drugs: the role of inactivation. J Membr Biol 122: 267–278
Grant AO, Wendt DJ, Zilberter Y, Starmer CF (1993) Kinetics of interaction of disopyramide with the cardiac sodium channel: fast dissociation from open channels at normal rest potentials. J Membr Biol 136: 199–214
Nilius B, Benndorf K, Markwardt F (1987) Effects of lidocaine on single cardiac sodium channels. J Mol Cell Cardio119: 865–874
Baumgarten CM, Makielski JC, Fozzard HA (1991) External site for local anesthetic block of cardiac Na+ channels. J Mol Cell Cardiol 23 [Suppl 1]: 85–93
Grant AO, Dietz MA, Gilliam III FR, Starmer CF (1989) Blockade of cardiac sodium channels by lidocaine: single channel analysis. Circ Res 65: 1247–1262
Benz I, Kohlhardt M (1992) Differential response of DPI-modified cardiac Na+ channels to antiarrhythmic drugs: no flicker blockade by lidocaine. J Membr Biol 126: 257–263
Kohlhardt M, Fichtner H, Froebe U, Herzig JW (1989) On the mechanism of drug-induced. blockade of Na* current: interaction of antiarrhythmic compounds with DPI-modified single cardiac Na+ channels. Circ Res 64: 867–881
Carmeliet E, Nilius B, Vereecke J (1989) Properties of the block of single Na+ channels in guinea-pig ventricular myocytes by the local anesthetic penticainide. J Physiol (Lond) 409: 241–262
Kohlhardt M, Frobe U, Herzig JW (1986) Modification of single cardiac Na+ channels by DPI 201–206. J Membr Biol 89: 163–172
Holloway SF, Salgado VL, Wu CH, Narahashi T (1989) Kinetic properties of single sodium channels modified by fenvalerate in mouse neuroblastoma cells. Pflugers Arch 414: 613–621
El-Sherif N, Fozzard HA, Hanck DA (1992) Dose-dependent modulation of the cardiac sodium channel by sea anemone toxin ATX11. Circ Res 70: 285–301
Quandt FN (1987) Burst kinetics of sodium channels which lack fast inactivation in mouse neuroblastoma cells. J Physiol (Lond) 392. 563–585
Courtney KR (1988) Why do some drugs preferentially block open sodium channels? J Mol Cell Cardiol 20: 461–464
Campbell TJ (1983) Kinetics of onset of rate-dependent effects of class 1 antiarrhythmic drugs are important in determining their effects on refractoriness in guinea pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc Res 17: 344–352
Campbell TJ (1983) Resting and rate-dependent depression of maximum rate of depolarization (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide and encainide. J Cardiovasc Pharmacol 5: 291–296
Campbell TJ, Vaughan Williams EM (1983) Voltage-and time-dependent depression of maximum rate of depolarization of guinea-pig ventricular action potential by two new antiarrhythmic drugs, flecainide and lorcainide. Cardiovasc Res 17: 251–258
Courtney KR (1990) Sodium channel blockers: the size/solubility hypothesis revisited. Mol Pharmacol 37: 855–859
Gruber R, Carmeliet E (1989) The activation gate of the sodium channel controls blockade and deblockade by disopyramide in rabbit Purkinje fibres. Br J Pharmacol 97: 41–50
Schwarz W, Palade PT, Hille B (1977) Local anesthetics: effect of pH on use-dependent block of sodium channels in frog muscle. Biophys J 20: 343–368
Grant AO, Strauss LJ, Wallace AG, Strauss HC (1982) The influence of pH on the electrophysiological effects of lidocaine in guinea pig ventricular myocardium. Circ Res 47: 542–550
Grant AO, Trantham JL, Brown KK, Strauss HC (1982) pH dependent effects of quinidine on the kinetics of dV/dtmax in guinea-pig ventricular myocardium. Circ Res 50: 210–217
Wendt DJ, Starmer CF, Grant AO (1993)pH dependence of kinetics and steady-state block of cardiac sodium channels by lidocaine. Am J Physiol 264:H1588 - H1598
Weirich J, Antoni H (1990) Differential analysis of the frequency-dependent effects of class 1 antiarrhythmic drugs according to periodic ligand binding: implications for antiarrhythmic and proarrhythmic effacy. J Cardiovasc Pharmaco 115: 998–1009
Anno T, Hondeghem LM (1990) Interaction of flecainide with guinea pig cardiac sodium channels. Importance of activation unblocking to the voltage dependene of recovery. Circ Res 66: 789–803
Carmeliet E (1988) Activation block and trapping of penticainide, a disopyramide analogue, in the Na+ channel of rabbit cardiac Purkinje fibers. Circ Res 63: 50–60
Campbell TJ (1992) Subclassification of class 1 antiarrhythmic drugs: enhanced relevance after CAST. Cardiovasc Drugs Ther 6: 519–528
Hondeghem LM (1976) Effects of lidocaine phenytoin and quinidine on ischemic canine myocardium. J Electrocardiol 9: 203–209
Ye VZ, Wyse KR, Campbell TJ (1993) Lidocaine shows greater selective depression of depolarized and acidotic myocardium than propafenone: possible implications for pro-arrhythmia. J Cardiovasc Pharmacol 21: 47–55
Gupta PK, Lichstein E, Chadda KD (1974) Lidocaine-induced heart block in patients with bundle branch block. Am J Cardiol 33. 487–492
Duff HJ, Roden D, Primm RK, Oates JA, Woosley RL (1983) Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects of combination with quinidine. Circulation 67: 1124–1128
Bellet S, Hamdan G, Somlyo A, Lara R (1959) The reversal of cardiotoxic effects of quinidine by molar sodium lactate: an experimental study. Am J Med Sci 237: 165–176
Bellet S, Hamdan G, Somlyo A, Lara R (1959) A reversal of cardiotoxic effects of procainamide. Am J Med Sci 237: 177–189
Pentel P, Benowitz N (1984) Efficacy and mechanism of action of sodium bicarbonate in the treatment of desipramine toxicity in rats. J Pharmacol Exp Ther 230: 12–19
Cahalan MD, Almers W (1979) Interaction between quaternary lidocaine, the sodium channel gates and tetrodotoxin. Biophys J 27: 39–56
Barber MJ, Wendt DJ, Starmer CF, Grant AO (1992) Blockade of cardiac sodium channels. Competition between the permeant ion and antiarrhythmic drugs. J Clin Invest 90: 368–381
Whalley DW, Wendt DJ, Grant AO (1993) Electrophysiological effects of acute ischemia and their role in the genesis of cardiac arrhythmias. In: Podrid PJ, Kowey PR (ed) Cardiac;arrhythmias: mechanism, diagnosis and management Williams and Wilkin, Baltimore (in press)
Morady F, Kou WH, Kadish AH et al. (1988) Antagonism of quinidine’s electrophysiologic effect by epinephrine in patients with ventricular tachycardia. J Am Coll Cardiol 12: 388–394
Jazayeri MR, Van Wyhe G, Akhtan M (1989) Isoproterenol reversal at antiarrhythmic effects in patients with inducible sustained tachyarrhythmias. J Am Coll Cardiol 14: 705-711
Markel ML, Miles WM, Luck JC, Klein LS, Prystowsky EN (1993) Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy. Circulation 87:783–792
Ranger S, Talagic M, Lemery R, Roy D, Nattel S (1989) Amplification of flecainide-induced ventricular conduction slowing by exercise. Circulation 79: 1000–1006
Myerburg R, Kessler KM, Cox MM, Huikun H, Terracall E, Interian A Jr, Fernandez P, Castellanos A (1989) Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol. Circulation 80: 1571–1579
Cachelin AB, de Peyer JE, Kokubun S, Reuter H (1983) Caz+ channel modulation by 8-bromocyclic AMP in cultured heart cells. Nature 304: 462–464
Yue DT, Herzig S, Marban E (1990) ß-Adrenergic stimulation of calcium channels occur by potentiation of high-activity gating modes. Proc Nat Acad Sci USA 87: 753–757
Windisch H, Tritthart HA (1982) Isoproterenol, norepinephrine and phosphodiesterase inhibitors are blockers of the depressed fast Na+-system in ventricular muscle fibers. J Mol Cell Cardiol 14: 431–434
Histome I, Kiyosue T, Imanishi S, Arita M (1985) Isoproterenol inhibits residual fast channel via stimulation of ß-adrenoceptors in guinea-pig ventricular muscle. J Mol Cell Cardiol 17: 657–665
Gillis AM, Kohlhardt M (1988) Voltage-dependent Vmax blockade in Na+-dependent action potentials after ß1 and H2-receptor stimulation in mammalian ventricular myocardium.1 Can J Physiol Pharmacol 66: 1291–1296
Schubert B, VanDongen AMJ, Kirsh GE, Brown AM (1989) β-Adrenergic inhibition of cardiac sodium channels by dual G-protein pathways. Science 245:516–519
Ono K, Kiyosue T, Arita M (1989) Isoproterenol, DBcAMP and forskolin inhibit cardiac sodium current. Am J Physiol 256:C1131- C1137
Schubert B, VanDongen AMJ, Kirsh GE, Brown AM (1990) Inhibition of cardiac Na+ currents by isoproterenol. Am J Physiol 258:H977-H 982
Matsuda JJ, Lee H, Shibata EF (1992) Enhancement of rabbit cardiac sodium channels by ß-adrenergic stimulation. Circ Res 70: 199–207
Kirstein M, Eickhorn R, Langfeld H, Kochsiek K, Antoni H (1991) Influence of ß-adrenergic stimulation of the fast sodium current in the intact rat papillary muscle. Basic Res Cardiol 86: 441–448
Ono K, Fozzard HA, Hanck D (1993) On the mechanism of cAMP-dependent modulation of cardiac sodium channel current kinetics. Circ Res 72: 807–815
Lee H-C, Matsuda JJ, Reynerston SI, Martins JB, Shibata EF (1993) Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells. J Clin Invest 91: 693–701
Catterall WA (1992) Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev 72: 515–548
Cohen SA, Barchi RL (1993) Voltage-dependent sodium channels. Int Rev Cytol 137C: 55–103
Vassilev P, Scheuer T, Catterall WA (1989) Inhibition of single sodium channels by a site-directed antibody. Proc Natl Acad Sci USA 86: 8147–8151
Stuehmer W, Conti F, Suzuki H, Wang X, Noda M, Yahagi N, Kubo H, Numa S (1993) Structural parts involved in activation and inactivation of the sodium channel. Nature 339: 597–603
Noda M, Ikeda T, Suzuki T, Takeshima H, Numa S (1986) Expression of functional sodium channels from cloned cDNA. Nature 322: 826–828
Noda M, Suzuki S, Numa S, Stuhmer WA (1989) A single point mutation confers tetrodo-toxin and saxitoxin insensitivity on the sodium channel II. FEBS Lett 259: 213–216
Heinemann SH, Terlau H, Imoto K (1992) Molecular basis for pharmacological differences between brain and cardiac sodium channels. Pflugers Arch 422: 90–92
Backx PH, Yue DT, Lawrence JH, Marban E, Tomaselli GF (1992) Molecular localization of an ion-binding site within the pore of mammalian sodium channels. Science 257: 248–251
Satin J, Kyle JW, Chen M, Bell P, Cribbs LL, Fozzard HA, Rogart RB (1992) A mutant of TTX-resistant cardiac sodium channels with TTX-sensitive properties. Science 256: 1202–1205
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Grant, A.O. (1995). Sodium Channel Blockade as an Antiarrhythmic Mechanism. In: Breithardt, G., Borggrefe, M., Camm, A.J., Shenasa, M., Haverkamp, W., Hindricks, G. (eds) Antiarrhythmic Drugs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85624-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-85624-2_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85626-6
Online ISBN: 978-3-642-85624-2
eBook Packages: Springer Book Archive